Загрузка...
Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)
BACKGROUND: Immunotherapy has revolutionised the treatment of advanced cutaneous squamous cell carcinoma (cSCC). It is important to understand both safety and efficacy in a real-world and trial-ineligible cSCC population. We aimed to evaluate safety, efficacy and molecular insights among a broader c...
Сохранить в:
| Опубликовано в: : | Br J Cancer |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7653959/ https://ncbi.nlm.nih.gov/pubmed/32868898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-020-01044-8 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|